ArticleInternational journal of endocrinology2022

Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study.

Tao Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.